The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease

BACKGROUND: People with chronic kidney disease (CKD) are at an increased risk of developing hyperkalaemia due to their declining kidney function. In addition, these patients are often required to reduce or discontinue guideline-recommended renin-angiotensin-aldosterone system inhibitor (RAASi) thera...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Nephrol
Hoofdauteurs: Evans, Marc, Palaka, Eirini, Furuland, Hans, Bennett, Hayley, Linde, Cecilia, Qin, Lei, McEwan, Phil, Bakhai, Ameet
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2019
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357372/
https://ncbi.nlm.nih.gov/pubmed/30704421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1228-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items